Revenue for Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's current revenue (TTM) is $36.77B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AMGN
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$36.77B
YoY change
+9.9%
5Y CAGR
+7.6%
Peak year (2025)
$36.74B
Cumulative revenue
$497.72B
Revenue history chart for Amgen (AMGN) from 1985 to 2025
Revenue history table for Amgen (AMGN) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $36.74B | +9.9% | ||
| 2024 | $33.42B | +18.6% | ||
| 2023 | $28.19B | +7.1% | ||
| 2022 | $26.32B | +1.3% | ||
| 2021 | $25.98B | +2.2% | ||
| 2020 | $25.42B | +8.8% | ||
| 2019 | $23.36B | -1.6% | ||
| 2018 | $23.75B | +3.9% | ||
| 2017 | $22.85B | -0.6% | ||
| 2016 | $22.99B | +6.1% | ||
| 2015 | $21.66B | +8.0% | ||
| 2014 | $20.06B | +7.4% | ||
| 2013 | $18.68B | +8.2% | ||
| 2012 | $17.27B | +10.8% | ||
| 2011 | $15.58B | +3.5% | ||
| 2010 | $15.05B | +2.8% | ||
| 2009 | $14.64B | -2.4% | ||
| 2008 | $15.00B | +1.6% | ||
| 2007 | $14.77B | +3.5% | ||
| 2006 | $14.27B | +14.8% | ||
| 2005 | $12.43B | +17.8% | ||
| 2004 | $10.55B | +26.3% | ||
| 2003 | $8.36B | +51.3% | ||
| 2002 | $5.52B | +37.5% | ||
| 2001 | $4.02B | +16.5% | ||
| 2000 | $3.45B | +7.6% | ||
| 1999 | $3.20B | +21.3% | ||
| 1998 | $2.64B | +12.6% | ||
| 1997 | $2.35B | +6.7% | ||
| 1996 | $2.20B | +15.5% | ||
| 1995 | $1.90B | +17.5% | ||
| 1994 | $1.62B | +19.6% | ||
| 1993 | $1.35B | +25.4% | ||
| 1992 | $1.08B | +58.9% | ||
| 1991 | $679.80M | +257.0% | ||
| 1990 | $190.40M | — | ||
| 1988 | $70.20M | +58.5% | ||
| 1987 | $44.30M | +48.7% | ||
| 1986 | $29.80M | +41.2% | ||
| 1985 | $21.10M | — |
Revenue values are taken from Amgen's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Amgen (AMGN) most recent annual revenue stands at $36.74B (2025) – grew 9.9% year-over-year.
Across 2020–2025 (5 years), Amgen revenue produced a CAGR of +7.6% – sustaining 6 straight years of year-over-year growth.
Across the available history, revenue reached its high of $36.74B in 2025 and its low of $21.10M in 1985.
Among 8 Healthcare peers, Amgen (AMGN) ranks 9th; the peer median for revenue is $65.09B.
Amgen Revenue by Year
Amgen Revenue 2025: $36.74B
Amgen revenue in 2025 was $36.74B, grew 9.9% from 2024. This figure represents the highest annual value in the available history.
Amgen Revenue 2024: $33.42B
Amgen revenue in 2024 was $33.42B, grew 18.6% from 2023.
Amgen Revenue 2023: $28.19B
Amgen revenue in 2023 was $28.19B, grew 7.1% from 2022.
Amgen Revenue 2022: $26.32B
Amgen revenue in 2022 was $26.32B, edged up 1.3% from 2021.
Amgen Revenue 2021: $25.98B
Amgen revenue in 2021 was $25.98B.
See more financial history for Amgen (AMGN).
Sector peers — Revenue
Companies in the same sector as Amgen, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $44.56B | Healthcare |
Frequently asked questions
What is Amgen's revenue?
- Latest reported revenue for Amgen (AMGN) is $36.77B (period ending December 31, 2025).
How has Amgen revenue changed year-over-year?
- Amgen (AMGN) revenue changed +9.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Amgen revenue?
- Amgen (AMGN) revenue compound annual growth rate is +7.6% over the most recent 5 years available.
When did Amgen revenue hit its highest annual value?
- Amgen revenue reached its highest annual value of $36.74B in 2025.
What was Amgen revenue in 2024?
- Amgen (AMGN) revenue in 2024 was $33.42B.
What was Amgen revenue in 2025?
- Amgen (AMGN) revenue in 2025 was $36.74B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AMGN Overview
Company profile, financial tools, and key metrics
AMGN Revenue Counter
Earns $1,166 every second. See per minute, hour, and day.
AMGN Earnings Counter
Earns $244.51 per second net profit. See per minute, hour, and day.
AMGN Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
AMGN What If Invested
What if you had invested $1,000? See historical returns from any date.
AMGN How It Makes Money
Discover visual breakdown of $36.77B in revenue — where it comes from and where it goes.
AMGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AMGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AMGN Daily Price Character
Balanced · 48.1% historical win rate (green days). Streaks & record days.
AMGN Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
AMGN Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
AMGN Dividend Profile
Yield: 2.86%. Safety: 8/8. See full history.
AMGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AMGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.